Please use this identifier to cite or link to this item:
https://repository.cihe.edu.hk/jspui/handle/cihe/4040
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, Stella Sze Wa | en_US |
dc.contributor.other | Hu, M. | - |
dc.contributor.other | Ko, S. S. W. | - |
dc.contributor.other | Tam, C. W. Y. | - |
dc.contributor.other | Fok, B. S. P. | - |
dc.contributor.other | Yin, O. Q. P. | - |
dc.contributor.other | Chow, M. S. S. | - |
dc.contributor.other | Tomlinson B. | - |
dc.date.accessioned | 2023-06-19T07:29:10Z | - |
dc.date.available | 2023-06-19T07:29:10Z | - |
dc.date.issued | 2013 | - |
dc.identifier.uri | https://repository.cihe.edu.hk/jspui/handle/cihe/4040 | - |
dc.description.abstract | Purpose The pharmacokinetics (PK) of labetalol show wide inter-subject variability, but the genetic causes for this are largely undetermined. This study was performed to examine whether common polymorphisms in UGT1A1, UGT2B7, CYP2C19 and ABCB1 affect the PK of labetalol. Methods The PK of labetalol were determined in 37 Chinese healthy male subjects who took a single oral dose of 200 mg labetalol. Plasma concentrations of labetalol were determined by a high-performance liquid chromatographic method. Subjects were genotyped for the CYP2C19*2 and *3, UGT1A1 *6, *28 and *60, UGT2B7*2 and ABCB1 1236C>T, 2677G>T/A and 3435C>T polymorphisms. Results Subjects with the CYP2C19*2/*2 genotype had a higher peak concentration (255.5 ± 80.1 vs. 156.0 ± 66.3 ng/mL; P < 0.05) and area under the concentration–time curve (AUC<sub>o−∞</sub>; 1,473.7 ± 493.6 vs. 502.8 ± 176.1 ng⋅h/mL; P < 0.001) than subjects with the *1/*1 genotype, and heterozygotes had intermediate values. The common UGT polymorphisms, UGT1A1*6, *60 or *28, and UGT2B7*2 did not result in a significant effect. Subjects with ABCB1 2677TA or TT or ABCB1 3435TT genotypes had higher AUC<sub>o−∞</sub> and lower total clearance than the wild-types (P < 0.05), but this appeared to be related to the distribution of CYP2C19 genotypes. The CYP2C19 genotype appeared to be the only predictor of labetalol concentrations, accounting for approximately 60 % of the total variance in the AUC<sub>o−∞</sub>. Conclusion Our results suggest that the PK of labetalol are significantly affected by the common CYP2C19 polymorphisms in individuals of Chinese ethnicity. Future larger studies are needed to evaluate the effect of CYP2C19 and UGT1A1 polymorphisms on the PK of labetalol stereoisomers and the pharmacodynamic effects. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | European Journal of Clinical Pharmacology | en_US |
dc.title | CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects | en_US |
dc.type | journal article | en_US |
dc.identifier.doi | 10.1007/s00228-012-1428-x | - |
dc.contributor.affiliation | School of Health Sciences | en_US |
dc.relation.issn | 1432-1041 | en_US |
dc.description.volume | 69 | en_US |
dc.description.issue | 4 | en_US |
dc.description.startpage | 799 | en_US |
dc.description.endpage | 806 | en_US |
dc.cihe.affiliated | No | - |
item.languageiso639-1 | en | - |
item.fulltext | With Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
item.openairetype | journal article | - |
item.grantfulltext | open | - |
crisitem.author.dept | S.K. Yee School of Health Sciences | - |
Appears in Collections: | HS Publication |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
View Online | 223 B | HTML | View/Open | |
Check Library Catalogue | 138 B | HTML | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.